Diabetes Drug News - Latest Updates & Headlines
Eli Lilly plans to invest over USD 1 billion in new contract manufacturing in India, to establish new manufacturing and quality presence in Hyderabad
Hyderabad October 6: In a major decision, US pharma giant Eli Lilly and Company (India) has said that it plans to invest more than USD1 billion over the next several years into new contract manufacturing in India, expanding patients' access to innovative medicines around the world.
DCGI alerts doctors, health professionals on theft of multiple drug products of Novo Nordisk
By Shalini Bhardwaj, New Delhi, August 22: India's drug regulator has alerted on the theft of multiple drug products of Novo Nordisk during transit.
Indian pharma market up by 7.9pc in July, cardiac & anti-diabetes therapies show strong volume
New Delhi, Aug 8: The Indian pharmaceutical market (IPM) grew 7.9 per cent in July this year, and the cardiac and anti-diabetes therapy segments have shown strong volume, according to a report.
'Decide within 3 months': Delhi HC tells CDSCO on plea against use of diabetes drugs in weight management
New Delhi, July 2: The Delhi High Court on Wednesday directed the Central Drugs Standard Control Organisation (CDSCO) to decide, within 3 months, a representation raising safety concerns on the usage of GLP-1-RA drugs in weight management and aesthetic treatment.
Study shows diabetes drug may help treat prostate cancer
New Delhi, May 7: Certain drugs used to treat type 2 diabetes can also be used to treat prostate cancer, according to a study.
Common diabetes drug may help manage knee arthritis, obesity
New Delhi, April 25: A common diabetes drug can help reduce pain in people with knee osteoarthritis (OA) and obesity, as well as delay the need for knee replacements, revealed a study on Friday.